J Gynecol Oncol.  2019 Nov;30(6):e113. 10.3802/jgo.2019.30.e113.

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study

Affiliations
  • 1Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan. mmikami@is.icc.u-tokai.ac.jp
  • 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
  • 3Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • 4Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan.

Abstract

No abstract available.


MeSH Terms

Drug Therapy*
Japan*
Joints*
Ovarian Neoplasms*
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr